A new pharmaceutical candidate enters Lundbecks development pipeline H.

Extensive research in pets suggests that these type of compounds have potential in e.g. Alzheimer’s disease, Huntington’s chorea and schizophrenia. Our Focus at Lundbeck Analysis is to discover innovative compounds that address unmet needs in sufferers with CNS diseases. About Lundbeck H. Lundbeck A/S is an international pharmaceutical company highly focused on improving the standard of life for folks experiencing central nervous program disorders. For this purpose, Lundbeck is involved in the extensive research, development, production, marketing and sale of pharmaceuticals across the world.At this conference, you shall have the chance to meet true market leaders, top speakers and actual experts from pharmaceutical industry. Usually do not miss the opportunity to gain new understanding and join us as of this event of the entire year. Key audio speakers: Senior Vice President, Global Advertising, Bayer Healthcare, Germany Mind of Marketing, Specialty Care Business Device, Pfizer, Finland Director Strategic Advertising, Member of the Executive Committee, Abbott, Switzerland Head of Marketing Scandinavia, UCB, Norway Associate Director, EMEA Advertising, Baxter, Switzerland Vice President, Franchise & Global Marketing Functions, Sanofi Pasteur, France Founder and handling director of Webicina.com, Author of Scienceroll.com, University of Debrecen Medical School and Health Senior Advertising Director, Pfizer, UK Executive Director, Global Marketing Excellence, Johnson & Johnson, UK Key topics: Case studies from top pharmaceutical businesses on how to focus on the most interesting segments through different stations Understand, how to utilize the potential of mobile phone advertising & achieve greater brand interactivity and immediate response metrics for your brands.